DR.Chip Biotechnology Incorporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 19.282 million compared to TWD 22.644 million a year ago. Operating loss was TWD 5.643 million compared to TWD 6.834 million a year ago. Net loss was TWD 3.662 million compared to TWD 5.682 million a year ago. Basic loss per share from continuing operations was TWD 0.08 compared to TWD 0.12 a year ago. For the half year, total revenue was TWD 44.270 million compared to TWD 43.753 million a year ago. Operating loss was TWD 9.697 million compared to TWD 17.543 million a year ago. Net loss was TWD 6.194 million compared to TWD 15.269 million a year ago. Basic loss per share from continuing operations was TWD 0.13 compared to TWD 0.32 a year ago.